calcipotriene (calcipotriol)

Subscribe to Selected New Research on calcipotriene

478 relevant articles (138 outcomes, 125 trials/studies) found for this Drug

Description: a topical dermatologic for the treatment of moderate plaque psoriasis; structure in first source

Also Known As:

calcipotriol; 1,24(OH)2-22-ene-24-cyclopropyl D3; Bristol-Myers Squibb brand of calcipotriene; CSL brand of calcipotriene; Daivonex; Dovonex; Farmacusi brand of calcipotriene; Leo brand of calcipotriene; MC 903; MC-903; Psorcutan; Schering brand of calcipotriene; Senosiain brand of calcipotriene; 9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-, (1alpha,3beta,5Z,7E,22E)-

Relationship Network

Drug Context: Research Results

Experts

1.	Kragballe, K: 7 articles (06/2006 - 01/2002)
2.	van de Kerkhof, P C M: 6 articles (02/2008 - 02/2004)
3.	Cambazard, F: 4 articles (06/2006 - 01/2002)
4.	Barnes, L: 4 articles (06/2006 - 04/2000)
5.	Chu, A C: 4 articles (04/2006 - 09/2001)
6.	Alhaddar, J: 4 articles (01/2005 - 01/2003)
7.	Ortonne, J P: 4 articles (06/2004 - 01/2002)
8.	Duweb, G A: 4 articles (01/2004 - 01/2000)
9.	Kaufmann, R: 4 articles (01/2004 - 01/2001)
10.	Altmeyer, P: 4 articles (02/2002 - 04/2000)

Related Diseases

1.	Psoriasis (Pustulosis Palmaris et Plantaris) 07/01/2000 - "Given the greater safety and efficacy of combination regimens in terms of both short-term improvement and long-term control, initiating psoriasis treatment with a combination regimen of topical calcipotriene combined with an ultrapotent corticosteroid appears to be the most cost-effective approach to psoriasis treatment." 04/01/1994 - "At the end of the study period 60% of patients on calcipotriol showed clearance or marked improvement of their psoriasis compared with 17% on placebo. " 09/01/1996 - "Calcipotriol is effective in the treatment of psoriasis and it is an important addition to the therapeutic medications available to treat psoriasis. " 07/01/1994 - "Topical treatment of psoriasis with calcipotriol has been proven effective. " 01/01/2005 - "Topical Calcipotriol is an effective treatment for nail psoriasis and can be considered to be a safe topical treatment in chronic cases; its high tolerability allows prolonged usage without severe side effects." Order ALL the reference details at left...
2.	Vitiligo 09/01/2001 - "CONCLUSIONS: Topical calcipotriol appears to be an effective and well-tolerated treatment for vitiligo and can be safely used in conjunction with PUVA, but controlled studies are necessary to exclude the possibility of spontaneous repigmentation." 05/01/2003 - "Is the combination of calcipotriol and PUVA effective in vitiligo?" 03/01/2002 - "RESULTS AND CONCLUSIONS: Topical calcipotriol in monotherapy is not an effective treatment of vitiligo." 03/01/2001 - "Calcipotriol is effective in certain keratinization disorders (ichtyoses) as well as in localized sclerodermia and vitiligo, although the effect is less certain for the latter conditions. " 05/01/2006 - "OBJECTIVE: The aim of the present study was to compare the clinical efficacy of NB-UVB and NB-UVB plus topical calcipotriol in the treatment of vitiligo. " Order ALL the reference details at left...
3.	Erythema 02/01/2002 - "Calcipotriol for erythema annulare centrifugum." 06/01/2000 - "No difference in erythema was seen between calcipotriol medication and the vehicle controls. " 06/01/2000 - "Calcipotriol ointment and cream were applied in 19 and 18 subjects, respectively, and erythema was measured for each application time quantified. " 06/01/2000 - "Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema." 10/01/1996 - "The pustules, increased skin fragility, tender oedema and erythema were successfully controlled by the local administration of calcipotriol." Order ALL the reference details at left...
4.	Pruritus (Itching) 04/01/2007 - "RESULTS: Observation on local lesion showed that the scores of erythema, infiltration, scaly eruption, pruritus were significantly improved in difference between the CEBO group and the Daivonex group (P < 0.01). " 04/01/2007 - "The ITSI of pruritus was shorter in CEBO group than that in the Daivonex group and the placebo group (P < 0.01), but that of other symptoms showed insignificant difference between the CEBO group and the Daivonex group, as for comparing in ITSI of erythema, infiltration, scaly eruption and pruritus, it was significantly shorter in the CEBO group and Daivonex group than that in the placebo group respectively (P < 0.01). " 06/01/2004 - "Side effects reported were erythema (one patient) and increased pruritus (two patients), all with calcipotriol. " 12/01/2000 - "Considerable additional reductions (38%-50%) in overall severity of plaque psoriasis, plaque elevation, scaling, pruritus, and overall discomfort were achieved over and above improvements already achieved with calcipotriene therapy. " 01/01/2000 - "No significant adverse effects were reported in either group except in two patients (8.3%) in the calcipotriol group who developed signs of irritation including itching and erythema. " Order ALL the reference details at left...
5.	Localized Scleroderma (Morphea) 08/01/1998 - "CONCLUSION: Topical calcipotriene 0.005% ointment may be an effective treatment for localized scleroderma, but double-blind placebo controlled studies are needed for confirmation." 08/01/1998 - "METHODS: In a 3-month open-label study, 12 patients aged 12 to 38 years with biopsy-documented active morphea or linear scleroderma applied calcipotriene ointment under occlusion twice daily to plaques for 3 months. " 08/01/1998 - "OBJECTIVE: The purpose of this study was to evaluate the efficacy and safety of topical calcipotriene 0.005% ointment in the treatment of localized scleroderma. " 12/01/2003 - "Topical calcipotriol ointment in the treatment of morphea." 08/01/1998 - "Topical calcipotriene for morphea/linear scleroderma." Order ALL the reference details at left...

Related Drugs and Biologics

1.	betamethasone-17,21-dipropionate (betamethasone dipropionate)
2.	Calcitriol (Calcijex)
3.	Betamethasone (Celestone)
4.	Anthralin (Dithranol)
5.	1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)
6.	calcipotriene (calcipotriol)
7.	Cholecalciferol (Vitamin D3)
8.	tazarotene (Tazorac)
9.	Cyclosporine (Ciclosporin)
10.	daivobet

Related Therapies and Procedures

1.	Phototherapy (Light Therapy)
2.	PUVA Therapy
3.	Day Care (Partial Hospitalization)
4.	Aftercare (After-Treatment)
5.	Therapeutics

Best Treatments:
Research Summary Report
on Psoriasis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1387 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>